State of New Jersey Common Pension Fund D’s Rigel Pharmaceuticals RIGL Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-85,000	Closed	-$2.22M	–	1633
2019 Q2	$2.22M	Hold	85,000	–	–	0.01%	732
2019 Q1	$2.19M	Hold	85,000	–	–	0.01%	729
2018 Q4	$1.96M	Hold	85,000	–	–	0.01%	711
2018 Q3	$2.73M	Hold	85,000	–	–	0.01%	703
2018 Q2	$2.41M	Hold	85,000	–	–	0.01%	749
2018 Q1	$3.01M	Hold	85,000	–	–	0.01%	692
2017 Q4	$3.3M	Hold	85,000	–	–	0.01%	659
2017 Q3	$2.16M	Hold	85,000	–	–	0.01%	731
2017 Q2	$2.32M	Hold	85,000	–	–	0.01%	708
2017 Q1	$2.81M	Hold	85,000	–	–	0.01%	673
2016 Q4	$2.02M	Hold	85,000	–	–	0.01%	725
2016 Q3	$3.12M	Buy	85,000 +30,000	+55%	+$860K	0.01%	656
2016 Q2	$1.23M	Hold	55,000	–	–	0.01%	781
2016 Q1	$1.14M	Hold	55,000	–	–	0.01%	790
2015 Q4	$1.67M	Hold	55,000	–	–	0.01%	766
2015 Q3	$1.36M	Buy	+55,000	New	+$1.64M	0.01%	800

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State of New Jersey Common Pension Fund D's RIGL Position: Q3 2019 in Review

State of New Jersey Common Pension Fund D sold out of Rigel Pharmaceuticals (RIGL) in Q3 2019, closing a stake of 85,000 shares — an estimated $2.22M sold.

State of New Jersey Common Pension Fund D first reported a position in RIGL in Q3 2015 and held it in 16 quarters. The position peaked at $3.3M in Q4 2017. 131 funds tracked by Wall St. Rank hold RIGL as of Q3 2019.

State of New Jersey Common Pension Fund D reported no remaining Rigel Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
State of New Jersey Common Pension Fund D sold 85,000 Rigel Pharmaceuticals shares in Q3 2019, an estimated $2.22M.
State of New Jersey Common Pension Fund D first reported a position in Rigel Pharmaceuticals in Q3 2015 and held it in 16 quarters.
State of New Jersey Common Pension Fund D's Rigel Pharmaceuticals position peaked at $3.3M in Q4 2017.
131 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2019.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q3 2019, filed 23 Oct 2019.